Aquestive Therapeutics, Inc. (AQST) › Net IncomeAquestive Therapeutics, Inc. (AQST) — Net IncomeAnnual figures by period end, from SEC filings.2017-12-31: -$8.94M2018-12-31: -$61.38M2019-12-31: -$66.25M2020-12-31: -$55.78M2021-12-31: -$70.54M2022-12-31: -$54.41M2023-12-31: -$7.87M2024-12-31: -$44.14M2025-12-31: -$83.78M-$83.78M2017-12-31Net Income (USD)2025-12-31Period endedNet IncomeChange YoYSource filing2025-12-31-$83.78M—2026-03-04From 2025-01-012024-12-31-$44.14M—2026-03-04From 2024-01-012023-12-31-$7.87M—2025-03-05From 2023-01-012022-12-31-$54.41M—2024-03-05From 2022-01-012021-12-31-$70.54M—2023-03-31From 2021-01-012020-12-31-$55.78M—2022-03-08From 2020-01-012019-12-31-$66.25M—2021-03-09From 2019-01-012018-12-31-$61.38M—2020-03-11From 2018-01-012017-12-31-$8.94M—2019-03-14From 2017-01-01Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per ShareWeighted Average Diluted SharesEPS (Basic)